Lazar David E. (CIK 0001932843)

Latest company ownership

Role: Director
Shares held
2,800,000
Last filed at
Mar 10, 2025
Confidence Score
50.1
2025Q4
Confidence Score History
2024Q4 2025Q4
Shares held
155,838
Last filed at
Aug 4, 2025
Confidence Score
44.4
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
100,000
Last filed at
Jul 31, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 30, 2025 Aug 4, 2025 Cyclacel Pharmaceuticals, Inc. 10% Owner Sell 22.5 -6,750 -4.15% $83.4K
Feb 26, 2025 Feb 28, 2025 Cyclacel Pharmaceuticals, Inc. CEO Sell 16.3 -194,628,820 -100.00% $5.5M
Dec 26, 2024 Dec 31, 2024 FiEE, Inc. Director Buy 91.3 +1,456,980 5827.92% $50K
Jun 21, 2023 Jun 28, 2023 TITAN PHARMACEUTICALS INC CEO Sell 17.5 -3,747,968 -100.00% $4.6M
Jun 21, 2023 Jun 23, 2023 TITAN PHARMACEUTICALS INC CEO Sell 17.5 -3,747,968 -100.00% $4.6M
Jan 24, 2023 Jan 26, 2023 TITAN PHARMACEUTICALS INC CEO Buy 82.5 +57,500 1.56% $56.3K
Jul 6, 2022 Jul 8, 2022 TITAN PHARMACEUTICALS INC 10% Owner Buy 100.0 +2,226,190 152.03% $1.9M